Pro-Dex Inc. Insider Trading

PDEX

Last 12 months

Insiders sold $2.03M and bought nothing on the open market.

91% of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in May 2022.

Net open-market

−$2.03M

0 buys · 5 sales

Under a 10b5-1 plan

91%

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

May 2022

May 10, 2022

Get an email when PDEX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 11	Kirk Richard Lee Van Jr Chief Executive Officer	Sold10b5-1 plan 2 parts	765	$59.36 average	45K	1.0%	Form 4
Sep 9	Kirk Richard Lee Van Jr Chief Executive Officer	Sold10b5-1 plan 9 parts	19,235	$60.58 average	$1.17M	19%	Form 4
Sep 9	Alisha Charlton Chief Financial Officer	SoldNo plan 2 parts	2,300	$61.30 average	141K	9.5%	Form 4
May 21 – 22	Kirk Richard Lee Van Jr Chief Executive Officer	Sold10b5-1 plan 6 parts	10,000	$62.62 average	626K	10%	Form 4
Mar 16	Angelita Rebamontan Domingo Director	SoldNo plan	998	$47.24	47K	5.0%	Form 4
Apr 2, 2025	Nicholas John Swenson Director	SoldNo plan 2 parts	4,526	—	—	0.4%	Form 4
Apr 1, 2025	Raymond E Cabillot Director	Sold10b5-1 plan	7,263	$50.01	363K	2.6%	Form 4
Mar 28, 2025 – Mar 31, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 2 parts	1,678	$50.00 average	84K	0.6%	Form 4
Mar 26, 2025	Raymond E Cabillot Director	Sold10b5-1 plan	3,096	$50.13	155K	1.1%	Form 4
Mar 24, 2025 – Mar 25, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 3 parts	15,711	$50.23 average	789K	5.3%	Form 4
Mar 19, 2025 – Mar 20, 2025	Farnam Street Partners LP Large holder	Sold10b5-1 plan 2 parts	2,101	$50.00 average	105K	0.7%	Form 4
Mar 14, 2025	Raymond E Cabillot Director	Sold10b5-1 plan	5,151	$50.00	258K	1.7%	Form 4
Mar 10, 2025 – Mar 11, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 2 parts	12,806	$45.02 average	577K	4.0%	Form 4
Jan 30, 2025	Farnam Street Partners LP Large holder	Sold10b5-1 plan	1,100	$45.01	50K	0.3%	Form 4
Jan 27, 2025 – Jan 28, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 2 parts	13,458	$41.63 average	560K	4.0%	Form 4
Jan 23, 2025 – Jan 24, 2025	Farnam Street Partners LP Large holder	Sold10b5-1 plan 2 parts	2,271	$41.65 average	95K	0.7%	Form 4
Jan 21, 2025 – Jan 22, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 5 parts	9,202	$44.55 average	410K	2.6%	Form 4
Jan 16, 2025 – Jan 17, 2025	Farnam Street Partners LP Large holder	Sold10b5-1 plan 3 parts	8,313	$44.75 average	372K	2.4%	Form 4
Jan 14, 2025 – Jan 15, 2025	Raymond E Cabillot Director	Sold10b5-1 plan 2 parts	3,026	$45.18 average	137K	0.8%	Form 4
Jan 10, 2025 – Jan 13, 2025	Farnam Street Partners LP Large holder	Sold10b5-1 plan 2 parts	4,824	$46.93 average	226K	1.3%	Form 4
Nov 7, 2024	Alisha Charlton Chief Financial Officer	SoldNo plan	1,000	$40.02	40K	6.1%	Form 4

Sep 1110b5-1 plan
Kirk Richard Lee Van Jr
Chief Executive Officer · sold 765 at avg $59.36
45K
1.0% of stake
Sep 910b5-1 plan
Kirk Richard Lee Van Jr
Chief Executive Officer · sold 19,235 at avg $60.58
$1.17M
19% of stake
Sep 9No plan
Alisha Charlton
Chief Financial Officer · sold 2,300 at avg $61.30
141K
9.5% of stake
May 21 – 2210b5-1 plan
Kirk Richard Lee Van Jr
Chief Executive Officer · sold 10,000 at avg $62.62
626K
10% of stake
Mar 16No plan
Angelita Rebamontan Domingo
Director · sold 998 at $47.24
47K
5.0% of stake
Apr 2, 2025No plan
Nicholas John Swenson
Director · sold 4,526
—
0.4% of stake
Apr 1, 202510b5-1 plan
Raymond E Cabillot
Director · sold 7,263 at $50.01
363K
2.6% of stake
Mar 28, 2025 – Mar 31, 202510b5-1 plan
Raymond E Cabillot
Director · sold 1,678 at avg $50.00
84K
0.6% of stake
Mar 26, 202510b5-1 plan
Raymond E Cabillot
Director · sold 3,096 at $50.13
155K
1.1% of stake
Mar 24, 2025 – Mar 25, 202510b5-1 plan
Raymond E Cabillot
Director · sold 15,711 at avg $50.23
789K
5.3% of stake
Mar 19, 2025 – Mar 20, 202510b5-1 plan
Farnam Street Partners LP
Large holder · sold 2,101 at avg $50.00
105K
0.7% of stake
Mar 14, 202510b5-1 plan
Raymond E Cabillot
Director · sold 5,151 at $50.00
258K
1.7% of stake
Mar 10, 2025 – Mar 11, 202510b5-1 plan
Raymond E Cabillot
Director · sold 12,806 at avg $45.02
577K
4.0% of stake
Jan 30, 202510b5-1 plan
Farnam Street Partners LP
Large holder · sold 1,100 at $45.01
50K
0.3% of stake
Jan 27, 2025 – Jan 28, 202510b5-1 plan
Raymond E Cabillot
Director · sold 13,458 at avg $41.63
560K
4.0% of stake
Jan 23, 2025 – Jan 24, 202510b5-1 plan
Farnam Street Partners LP
Large holder · sold 2,271 at avg $41.65
95K
0.7% of stake
Jan 21, 2025 – Jan 22, 202510b5-1 plan
Raymond E Cabillot
Director · sold 9,202 at avg $44.55
410K
2.6% of stake
Jan 16, 2025 – Jan 17, 202510b5-1 plan
Farnam Street Partners LP
Large holder · sold 8,313 at avg $44.75
372K
2.4% of stake
Jan 14, 2025 – Jan 15, 202510b5-1 plan
Raymond E Cabillot
Director · sold 3,026 at avg $45.18
137K
0.8% of stake
Jan 10, 2025 – Jan 13, 202510b5-1 plan
Farnam Street Partners LP
Large holder · sold 4,824 at avg $46.93
226K
1.3% of stake
Nov 7, 2024No plan
Alisha Charlton
Chief Financial Officer · sold 1,000 at $40.02
40K
6.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PDEX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PDEX

CompareIntrinsic value

TELATela Bio Inc.

$0.87+8.72%30

SGHTSight Sciences, Inc.

$9.68+2.76%33

RCELAvita Medical Inc.

$16.32+6.46%30

IRMDIradimed Corp

$88.58+9.21%80

LUNGPulmonx Corporation

$2.83+4.04%30

DCTHDelcath Systems Inc.

$14.82+2.92%62

CARLCarlsmed, Inc.

$16.09+11.74%44

MHUAFMeihua International Medical Technologies Co., Ltd.

$6.30-8.16%59

Held by ETFs

PDEX is in 9 US ETFs. The largest of them, with PDEX's weight in each:

Spot a number that looks wrong? Check it in PDEX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PDEX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.